21 May 2013
Keywords: versant, hcv, assay, launched, europe, bayer, healthcare
Article | 27 November 2006
Bayer Healthcare, a division of Germany's Bayer group, and Belgian firm Innogenetics NV, have announced the European launch of their
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 November 2006
4 December 2006
20 May 2013
© 2013 thepharmaletter.com